The human neuregulin 1-beta1 (NRG1-beta1, amino acid residues 176-246) was chemically synthesized by Fmoc-based solid phase peptide synthesis (SPPS) followed by folding in a redox buffer. The biological activity of the synthesized NRG1-beta1 was confirmed by ligand-induced tyrosine phosphorylation on Chinese hamster ovary (CHO) cells expressing ErbB-4.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/psc.916 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Two Preparation Methods for Peptide Thioester Containing Tyr(SOH) Residue(s) without the Use of Protecting Group for Sulfate Moiety.
Chem Pharm Bull (Tokyo)
July 2024
Faculty of Pharamaceutical Sciences, Niigata University of Pharmacy and Medical and Life Sciences.
We report two methods for the preparation of peptide thioesters containing Tyr(SOH) residue(s), without use of a protecting group for the sulfate moiety. The first was based on direct thioesterification using carbodiimide on a fully protected peptide acid, prepared on a 2-chlorotrityl (Clt) resin with fluoren-9-ylmethoxycarbonyl (Fmoc)-based solid-phase peptide synthesis (Fmoc-SPPS). Subsequent deprotection of the protecting groups with trifluoroacetic acid (TFA) (0 °C, 4 h) yielded peptide thioesters containing Tyr(SOH) residue(s).
View Article and Find Full Text PDFDesign, synthesis and evaluation of bioactivity of peptidomimetics based on chloroalkene dipeptide isosteres.
Bioorg Med Chem
August 2024
Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), 2-3-10 Kandasurugadai, Chiyoda-ku, Tokyo 101-0062, Japan. Electronic address:
Ample biologically active peptides have been found, identified and modified for use in drug discovery to date. However, several factors, such as low metabolic stability due to proteolysis and non-specific interactions with multiple off-target molecules, might limit the therapeutic use of peptides. To enhance the stability and/or bioactivity of peptides, the development of "peptidomimetics," which mimick peptide molecules, is considered to be idealistic.
View Article and Find Full Text PDFA two-step method preparation of semaglutide through solid-phase synthesis and inclusion body expression.
Protein Expr Purif
July 2024
School of Chemistry and Chemical Engineering, Hunan Institute of Science and Technology, Yueyang, 414006, Hunan, China; Key Laboratory of Hunan Province for Advanced Carbon-based Functional Materials, School of Chemistry and Chemical Engineering, Hunan Institute of Science and Technology, Yueyang, 414006, Hunan, China. Electronic address:
Semaglutide is currently the most promising antidiabetic drug, especially for the treatment of type 2 diabetes mellitus, due to its excellent efficacy in glycemic control and weight loss. However, the production of semaglutide remains high cost, and high yield, low cost, and high purity still remains a challenge. Herein, we reported a convenient and high-yield strategy for the preparation of semaglutide through fragmented condensation coupling, involving solid-phase peptide synthesis of tetrapeptide and on-column refolding and on-column enzyme cleavage based inclusion body expression of LysArgGLP-1 (11-37) with fused protein tags in an X-Y-D4K-G pattern.
View Article and Find Full Text PDFSolid-Phase Synthesis and Biological Evaluation of Peptides ADP-Ribosylated at Histidine.
Angew Chem Weinheim Bergstr Ger
January 2024
The transfer of an adenosine diphosphate (ADP) ribose moiety to a nucleophilic side chain by consumption of nicotinamide adenine dinucleotide is referred to as ADP-ribosylation, which allows for the spatiotemporal regulation of vital processes such as apoptosis and DNA repair. Recent mass-spectrometry based analyses of the "ADP-ribosylome" have identified histidine as ADP-ribose acceptor site. In order to study this modification, a fully synthetic strategy towards α-configured N(τ)- and N(π)-ADP-ribosylated histidine-containing peptides has been developed.
View Article and Find Full Text PDFNatural carboxyterminal truncation of human CXCL10 attenuates glycosaminoglycan binding, CXCR3A signaling and lymphocyte chemotaxis, while retaining angiostatic activity.
Cell Commun Signal
February 2024
Laboratory of Molecular Immunology, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.
Article Synopsis
- Interferon-γ-inducible protein of 10 kDa (IP-10/CXCL10) functions as a chemokine that attracts activated T and NK cells by binding to its receptor CXCR3, although its natural posttranslational modifications, especially at the C-terminus, have not been fully understood.
- Research involved analyzing synovial fluid from rheumatoid arthritis patients to compare the levels of natural and intact CXCL10 using mass spectrometry and various biological assays to assess its effects on cell behavior.
- Findings revealed that natural CXCL10 was more prevalent and had reduced binding affinity for glycosaminoglycans and weaker signaling capabilities, indicating its diminished effectiveness in promoting immune cell migration and activation
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!